TG2 protects neuroblastoma cells against DNA-damage-induced stress, suppresses p53 activation

Amino Acids

Volumn 39, Issue 2, 2010, Pages 523-532

  Tucholski, Janusz ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Apoptosis; DNA damage; Etoposide; p53; Retinoic acid; TG2

Indexed keywords

CASPASE 3; COMPLEMENTARY DNA; ETOPOSIDE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; PROTEIN P53; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TISSUE TRANSGLUTAMINASE 2, HUMAN;

ARTICLE; CELL PROTECTION; CELL STRESS; DNA DAMAGE; ENZYME ACTIVITY; ENZYME INHIBITION; GENE ACTIVATION; GENE CONSTRUCT; GENE CONTROL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; WILD TYPE; DRUG EFFECTS; GENETICS; METABOLISM; NEUROBLASTOMA; PHYSIOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; DNA DAMAGE; HUMANS; NEUROBLASTOMA; TRANSGLUTAMINASES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84755161106     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-009-0468-8     Document Type: Article

References (73)

1. Achyuthan KE, Greenberg CS (1987) Identification of a guanosine triphosphate-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity. J Biol Chem 262:1901-1906
2. Ai L, Kim WJ, Demircan B, Dyer LM, Bray KJ, Skehan RR, Massoll NA, Brown KD (2008) The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer. Carcinogenesis 29:510-518
3. Antonyak MA, Singh US, Lee DA, Boehm JE, Combs C, Zgola MM, Page RL, Cerione RA (2001) Effects of tissue transglutaminase on retinoic acid-induced cellular differentiation and protection against apoptosis. J Biol Chem 276:33582-33587
4. Bailey CD, Johnson GV (2004) Developmental regulation of tissue transglutaminase in the mouse forebrain. J Neurochem 91:1369-1379
5. Barbieri E, Mehta P, Chen Z, Zhang L, Slack A, Berg S, Shohet JM (2006) MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell death. Mol Cancer Ther 5:2358-2365
6. Bastien J, Rochette-Egly C (2004) Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 328:1-16
7. Biedler JL, Spengler BA (1976) A novel chromosome abnormality in human neuroblastoma and antifolate-resistant Chinese hamster cell lives in culture. J Natl Cancer Inst 57:683-695
8. Buommino E, Pasquali D, Sinisi AA, Bellastella A, Morelli F, Metafora S (2000) Sodium butyrate/retinoic acid costimulation induces apoptosis-independent growth arrest and cell differentiation in normal and ras-transformed seminal vesicle epithelial cells unresponsive to retinoic acid. J Mol Endocrinol 24:83-94
9. Burden DA, Osheroff N (1998) Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme. Biochimica et Biophysica Acta (BBA) Gene Struct Expr 1400:139-154
10. Campisi A, Caccamo D, Raciti G, Cannavo G, Macaione V, Curro M, Macaione S, Vanella A, Ientile R (2003) Glutamate-induced increases in transglutaminase activity in primary cultures of astroglial cells. Brain Res 978:24-30
11. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849-852
12. Cui H, Schroering A, Ding HF (2002) p53 mediates DNA damaging drug-induced apoptosis through a caspase-9-dependent pathway in SH-SY5Y neuroblastoma cells. Mol Cancer Ther 1:679-686
13. Curro M, Condello S, Caccamo D, Ferlazzo N, Parisi G, Ientile R (2009) Homocysteine-induced toxicity increases TG2 expression in Neuro2a cells. Amino Acids 36:725-730
14. Datta S, Antonyak MA, Cerione RA (2006) Importance of Ca (2+) - dependent transamidation activity in the protection afforded by tissue transglutaminase against doxorubicin-induced apoptosis. Biochemistry 45:13163-13174
15. Davidoff AM, Pence JC, Shorter NA, Iglehart JD, Marks JR (1992) Expression of p53 in human neuroblastoma-and neuroepithelioma-derived cell lines. Oncogene 7:127-133
16. Encinas M, Iglesias M, Llecha N, Comella JX (1999) Extracellularregulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y. J Neurochem 73:1409-1421
17. Fabbi M, Marimpietri D, Martini S, Brancolini C, Amoresano A, Scaloni A, Bargellesi A, Cosulich E (1999) Tissue transglutaminase is a caspase substrate during apoptosis. Cleavage causes loss of transamidating function and is a biochemical marker of caspase 3 activation. Cell Death Differ 6:992-1001
18. Facchiano F, D'Arcangelo D, Riccomi A, Lentini A, Beninati S, Capogrossi MC (2001) Transglutaminase activity is involved in polyamine-induced programmed cell death. Exp Cell Res 271:118-129
19. Filiano AJ, Bailey CD, Tucholski J, Gundemir S, Johnson GV (2008) Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling. Faseb J 22:2662-2675
20. Gewirtz DA (1999) A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57:727-741
21. Han JA, Park SC (1999) Reduction of transglutaminase 2 expression is associated with an induction of drug sensitivity in the PC-14 human lung cancer cell line. J Cancer Res Clin Oncol 125:89-95
22. Hasegawa G, Suwa M, Ichikawa Y, Ohtsuka T, Kumagai S, Kikuchi M, Sato Y, Saito Y (2003) A novel function of tissue-type transglutaminase: protein disulphide isomerase. Biochem J 373:793-803
23. Ientile R, Caccamo D, Griffin M (2007) Tissue transglutaminase and the stress response. Amino Acids 33:385-394
24. Iismaa SE, Chung L, Wu MJ, Teller DC, Yee VC, Graham RM (1997) The core domain of the tissue transglutaminase Gh hydrolyzes GTP and ATP. Biochemistry 36:11655-11664
25. Jeong EM, Kim C-W, Cho S-Y, Jang G-Y, Shin D-M, Jeon J-H, Kim I-G (2009) Degradation of transglutaminase 2 by calcium mediated ubiquitination responding to high oxidative stress. FEBS Lett 583:648-654
26. Joshi S, Guleria R, Pan J, DiPette D, Singh US (2006) Retinoic acid receptors and tissue-transglutaminase mediate short-term effect of retinoic acid on migration and invasion of neuroblastoma SH-SY5Y cells. Oncogene 25:240-247
27. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F, Caput D (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90:809-819
28. Keshelava N, Zuo JJ, Chen P, Waidyaratne SN, Luna MC, Gomer CJ, Triche TJ, Reynolds CP (2001) Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines. Cancer Res 61:6185-6193
29. Kim SY, Grant P, Lee JH, Pant HC, Steinert PM (1999) Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminases 1 and 2 in Alzheimer's disease. J Biol Chem 274:30715-30721
30. Lavoie JF, Lesauteur L, Kohn J, Wong J, Furtoss O, Thiele CJ, Miller FD, Kaplan DR (2005) TrkA induces apoptosis of neuroblastoma cells and does so via a p53-dependent mechanism. J Biol Chem 280:29199-29207
31. Lee KN, Arnold SA, Birckbichler PJ, Patterson MK, Fraij BM Jr, Takeuchi Y, Carter HA (1993) Site-directed mutagenesis of human tissue transglutaminase: Cys-277 is essential for transglutaminase activity but not for GTPase activity. Biochim Biophys Acta 1202:1-6
32. Lesort M, Tucholski J, Zhang J, Johnson GV (2000a) Impaired mitochondrial function results in increased tissue transglutaminase activity in situ. J Neurochem 75:1951-1961
33. Lesort M, Tucholski J, Miller ML, Johnson GV (2000b) Tissue transglutaminase: a possible role in neurodegenerative diseases. Prog Neurobiol 61:439-463
34. Liu T, Tee AE, Porro A, Smith SA, Dwarte T, Liu PY, Iraci N, Sekyere E, Haber M, Norris MD, Diolaiti D, Della Valle G, Perini G, Marshall GM (2007) Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis. Proc Natl Acad Sci USA 104:18682-18687
35. Lorand L, Graham RM (2003) Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 4:140-156
36. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847-849
37. Mandrusiak LM, Beitel LK, Wang X, Scanlon TC, Chevalier-Larsen E, Merry DE, Trifiro MA (2003) Transglutaminase potentiates ligand-dependent proteasome dysfunction induced by polyglutamine-expanded androgen receptor. Hum Mol Genet 12:1497-1506
38. Maris JM, Hogarty MD, Bagatell R, Cohn SL (2007) Neuroblastoma. Lancet 369:2106-2120
39. Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM, Gerbing RB, Reynolds CP (1999) Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 341:1165-1173
40. McClendon AK, Osheroff N (2007) DNA topoisomerase II, genotoxicity, and cancer. Mutat Res 623:83-97
41. Mehta K (1994) High levels of transglutaminase expression in doxorubicin-resistant human breast carcinoma cells. Int J Cancer 58:400-406
42. Mehta K (2005) Mammalian transglutaminases: a family portrait. Prog Exp Tumor Res 38:1-18
43. Melino G, Annicchiarico-Petruzzelli M, Piredda L, Candi E, Gentile V, Davies PJ, Piacentini M (1994) Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells. Mol Cell Biol 14:6584-6596
44. Mian S, El Alaoui S, Lawry J, Gentile V, Davies PJ, Griffin M (1995) The importance of the GTP-binding protein tissue transglutaminase in the regulation of cell cycle progression. FEBS Lett 370:27-31
45. Mishra S, Murphy LJ (2006) The p53 oncoprotein is a substrate for tissue transglutaminase kinase activity. Biochem Biophys Res Commun 339:726-730
46. Murthy SN, Lomasney JW, Mak EC, Lorand L (1999) Interactions of G (h)/transglutaminase with phospholipase Cdelta1 and with GTP. Proc Natl Acad Sci USA 96:11815-11819
47. Nagy L, Saydak M, Shipley N, Lu S, Basilion JP, Yan ZH, Syka P, Chandraratna RA, Stein JP, Heyman RA, Davies PJ (1996) Identification and characterization of a versatile retinoid response element (retinoic acid receptor response element-retinoid X receptor response element) in the mouse tissue transglutaminase gene promoter. J Biol Chem 271:4355-4365
48. Nakaoka H, Perez DM, Baek KJ, Das T, Husain A, Misono K, Im MJ, Graham RM (1994) Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science 264:1593-1596
49. Pahlman S, Ruusala AI, Abrahamsson L, Mattsson ME, Esscher T (1984) Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbol ester-induced differentiation. Cell Differ 14:135-144
50. Piacentini M, Annicchiarico-Petruzzelli M, Oliverio S, Piredda L, Biedler JL, Melino E (1992) Phenotype-specific "tissue" transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: correlation with cell death by apoptosis. Int J Cancer 52:271-278
51. Piacentini M, Piredda L, Starace DT, Annicchiarico-Petruzzelli M, Mattei M, Oliverio S, Farrace MG, Melino G (1996) Differential growth of N-and S-type human neuroblastoma cells xenografted into SCID mice: correlation with apoptosis. J Pathol 180:415-422
52. Piacentini M, Farrace MG, Piredda L, Matarrese P, Ciccosanti F, Falasca L, Rodolfo C, Giammarioli AM, Verderio E, Griffin M, Malorni W (2002) Transglutaminase overexpression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stress. J Neurochem 81:1061-1072
53. Prives C, Hall PA (1999) The p53 pathway. J Pathol 187:112-126
54. Reynolds CP, Kane DJ, Einhorn PA, Matthay KK, Crouse VL, Wilbur JR, Shurin SB, Seeger RC (1991) Response of neuroblastoma to retinoic acid in vitro and in vivo. Prog Clin Biol Res 366:203-211
55. Robitaille K, Daviau A, Tucholski J, Johnson GV, Rancourt C, Blouin R (2004) Tissue transglutaminase triggers oligomerization and activation of dual leucine zipper-bearing kinase in calphostin C-treated cells to facilitate apoptosis. Cell Death Differ 11:542-549
56. Rodriguez-Lopez AM, Xenaki D, Eden TO, Hickman JA, Chresta CM (2001) MDM2 mediated nuclear exclusion of p53 attenuates etoposide-induced apoptosis in neuroblastoma cells. Mol Pharmacol 59:135-143
57. Ronca F, Yee KS, Yu VC (1999) Retinoic acid confers resistance to p53-dependent apoptosis in SH-SY5Y neuroblastoma cells by modulating nuclear import of p53. J Biol Chem 274:18128-18134
58. Ross RA, Spengler BA (2007) Human neuroblastoma stem cells. Semin Cancer Biol 17:241-247
59. Ross RA, Spengler BA, Biedler JL (1983) Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst 71:741-747
60. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S (2004) Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73:39-85
61. Sidell N, Koeffler HP (1988) Modulation of Mr 53, 000 protein with induction of differentiation of human neuroblastoma cells. Cancer Res 48:2226-2230
62. Singh US, Pan J, Kao YL, Joshi S, Young KL, Baker KM (2003) Tissue transglutaminase mediates activation of RhoA and MAP kinase pathways during retinoic acid-induced neuronal differentiation of SH-SY5Y cells. J Biol Chem 278:391-399
63. Szondy Z, Molnar P, Nemes Z, Boyiadzis M, Kedei N, Toth R, Fesus L (1997) Differential expression of tissue transglutaminase during in vivo apoptosis of thymocytes induced via distinct signalling pathways. FEBS Lett 404:307-313
64. Szondy Z, Sarang Z, Molnar P, Nemeth T, Piacentini M, Mastroberardino PG, Falasca L, Aeschlimann D, Kovacs J, Kiss I, Szegezdi E, Lakos G, Rajnavolgyi E, Birckbichler PJ, Melino G, Fesus L (2003) Transglutaminase 2-/-mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells. Proc Natl Acad Sci USA 100:7812-7817
65. Thiele CJ, Reynolds CP, Israel MA (1985) Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature 313:404-406
66. Tucholski J, Johnson GV (2002) Tissue transglutaminase differentially modulates apoptosis in a stimuli-dependent manner. J Neurochem 81:780-791
67. Tucholski J, Johnson GV (2003) Tissue transglutaminase directly regulates adenylyl cyclase resulting in enhanced cAMP-response element-binding protein (CREB) activation. J Biol Chem 278:26838-26843
68. Tucholski J, Kuret J, Johnson GV (1999) Tau is modified by tissue transglutaminase in situ: possible functional and metabolic effects of polyamination. J Neurochem 73:1871-1880
69. Tucholski J, Lesort M, Johnson GV (2001) Tissue transglutaminase is essential for neurite outgrowth in human neuroblastoma SH-SY5Y cells. Neuroscience 102:481-491
70. Tucholski J, Roth KA, Johnson GV (2006) Tissue transglutaminase overexpression in the brain potentiates calcium-induced hippocampal damage. J Neurochem 97:582-594
71. Tweddle DA, Malcolm AJ, Cole M, Pearson AD, Lunec J (2001) p53 cellular localization and function in neuroblastoma: evidence for defective G (1) arrest despite WAF1 induction in MYCN-amplified cells. Am J Pathol 158:2067-2077
72. Vousden KH (2000) p53: Death Star. Cell 103:691-694
73. Xiang H, Hochman DW, Saya H, Fujiwara T, Schwartzkroin PA, Morrison RS (1996) Evidence for p53-mediated modulation of neuronal viability. J Neurosci 16:6753-6765